Dalton obtains notice of award form NIDA for research
The award is intended to support the discovery of a novel series of potent compounds targeting drug abuse and alleviate pain. Dalton Medicinal Chemistry co-founder Judd Berman said,
Swedish Orphan Biovitrum (Sobi) has received a complete response letter from the US Food and Drug Administration (FDA) regarding its biologics licence application for nanoencapsulated sirolimus plus pegadricase (NASP), an investigational therapy intended for adults with uncontrolled gout.
Cegedim’s Mobile Intelligence via the cloud empowers companies with a centralized platform to consolidate interactions, improve governance and enhance strategy execution. Aptalis Pharma International Specialty Pharmaceuticals president Jean-Louis